Abstract

Objectives: To explore the potential of integrating genetic mapping and metabolomic analysis as innovative tools to personalize and enhance aesthetic treatments, as well as to guide the selection of the most appropriate approach—whether biostimulators, energy-based devices, lasers, or PDO threads—paving the way for a more precise and biologically individualized aesthetic medicine. Introduction: Aesthetic medicine faces limitations in outcomes when individual biological variability is disregarded. Genetic polymorphisms and metabolic imbalances can significantly influence therapeutic efficacy. This study proposes a novel approach that incorporates genomics and metabolomics as a foundation for personalized therapeutic strategies. Materials / method: A theoretical and practical framework is presented, based on the correlation between genetic data (e.g., NRF2, AQP, and MMP polymorphisms) and urinary metabolomic profiles. The goal is to tailor aesthetic interventions using individualized biomarker data. Strategies include targeted nutraceutical supplementation and selection of aesthetic modalities guided by each patient’s unique biochemical landscape. Results: Preliminary observations suggest that identifying genetic and metabolic predispositions may support more assertive decision-making in aesthetic procedures. Although clinical outcomes have not yet been formally measured, this hypothesis creates a foundation for future research and supports the scientific rationale for personalized protocols in aesthetic practice. Conclusion: Integrating precision medicine tools into aesthetics represents a paradigm shift. While promising, this approach requires clinical validation. Nevertheless, it marks the beginning of a new era in aesthetic medicine—one that honors biological individuality and anticipates the body’s intrinsic responses, moving beyond standard protocols toward truly personalized care.